RCT
Paid to Show the Drug Works: Why “Blind” Clinical Trials for New Drugs are Far Less Blind Than They Should Be
New research shows that physicians in industry-sponsored trials are more captured by pharmaceutical companies than physicians in unsponsored ones.
Economists love health care because it...
We Need More Respectful and Inclusive Experiments in Development Economics: A Proposal
After many years of field research in Uganda, three economists outline how to prevent a powerful research tool such as randomized controlled trials...
